- Home
- UNH vs AZN Comparison
UNH vs AZN Comparison
Compare UNH & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UNH | AZN |
|---|---|---|
| Founded | 1977 | 1992 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 264.5B | 285.7B |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | UNH | AZN |
|---|---|---|
| Price | $286.77 | $191.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 25 | 1 |
| Target Price | ★ $387.79 | N/A |
| AVG Volume (30 Days) | ★ 6.1M | 1.7M |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.07% | 1.67% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 13.23 | N/A |
| Revenue | ★ $447,567,000,000.00 | N/A |
| Revenue This Year | N/A | $10.13 |
| Revenue Next Year | $3.31 | $6.21 |
| P/E Ratio | ★ $21.69 | $31.91 |
| Revenue Growth | ★ 11.81 | N/A |
| 52 Week Low | $234.60 | $61.24 |
| 52 Week High | $606.36 | $212.71 |
Technical Indicators
Market Signals| Indicator | UNH | AZN |
|---|---|---|
| Relative Strength Index (RSI) | 48.05 | 56.00 |
| Support Level | $269.68 | $89.28 |
| Resistance Level | $294.66 | $211.32 |
| Average True Range (ATR) | 7.02 | 3.22 |
| MACD | 1.00 | -4.58 |
| Stochastic Oscillator | 56.79 | 8.54 |
Price Performance
Historical ComparisonAbout UNH UnitedHealth Group
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.